Baotou Tianhe Magnetics Technology
603072
HuangShan Googe
301581
Geovis Insighter Technology
920116
CHICHENG ELECTRIC
834407
Xdc Industries(Shenzhen)Limited
300615
CN Stock MarketDetailed Quotes
002900 Harbin Medisan Pharmaceutical
- 9.40
- -0.27-2.79%
Market Closed Jan 3 15:00 CST
2.97BMarket Cap54.97P/E (TTM)
9.80High9.40Low26.58KlotVolume9.72Open9.67Pre Close25.47MTurnover1.54%Turnover Ratio40.34P/E (Static)316.39MShares14.2052wk High1.39P/B1.63BFloat Cap6.5452wk Low10.64Limit Up173.16MShs Float36.30Historical High8.70Limit Down4.14%Amplitude6.47Historical Low0.20Dividend TTM9.58Avg Price15.25KlotAsk2.13%Div YieldTTM100Lot Size10.35KlotBid
Harbin Medisan Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -9.10%838.53M | -17.86%523.44M | -27.86%246.82M | 15.40%1.19B | 21.08%922.46M | 26.25%637.23M | 33.29%342.15M | 8.73%1.03B | 7.66%761.89M | 6.52%504.74M |
| Operating revenue | -9.10%838.53M | -17.86%523.44M | -27.86%246.82M | 15.40%1.19B | 21.08%922.46M | 26.25%637.23M | 33.29%342.15M | 8.73%1.03B | 7.66%761.89M | 6.52%504.74M |
| Other operating revenue | ---- | 91.66%33.68M | ---- | 68.22%34.09M | ---- | 77.35%17.57M | ---- | -42.77%20.27M | ---- | -16.65%9.91M |
| Total operating cost | -9.96%827.69M | -17.26%519.35M | -24.72%246.97M | 13.15%1.2B | 17.08%919.24M | 21.84%627.69M | 24.67%328.06M | -3.18%1.06B | 3.17%785.11M | 0.93%515.17M |
| Operating cost | 18.09%410.02M | 7.99%240.28M | -16.82%105.98M | 30.31%476.38M | 29.77%347.21M | 19.70%222.49M | 21.96%127.41M | 18.16%365.57M | 17.36%267.56M | 16.69%185.88M |
| Operating tax surcharges | -24.29%8.89M | -29.60%5.86M | -30.70%3.03M | -6.05%14.71M | -1.63%11.74M | 4.26%8.33M | 8.79%4.38M | 8.52%15.66M | 9.82%11.94M | 9.79%7.99M |
| Operating expense | -42.80%207.01M | -44.31%148.45M | -44.01%80.76M | -7.07%421.8M | 2.14%361.87M | 16.56%266.59M | 29.84%144.23M | -12.30%453.91M | 0.66%354.29M | -0.72%228.72M |
| Administration expense | 1.47%126.61M | -1.51%80.95M | 14.61%39.16M | 25.35%176.36M | 34.71%124.78M | 39.70%82.19M | 20.32%34.17M | -5.91%140.69M | -4.52%92.62M | -6.65%58.83M |
| Financial expense | 91.01%-369.95K | -15.26%-4.36M | -182.51%-6.66M | 36.81%-3.98M | 14.46%-4.12M | -5.43%-3.78M | -197.64%-2.36M | -324.93%-6.29M | -294.76%-4.81M | -281.71%-3.59M |
| -Interest expense (Financial expense) | 33.52%22.69M | 34.20%15.05M | 22.63%6.95M | 1.29%22.89M | 1.80%16.99M | 6.82%11.22M | 36.96%5.66M | 63.72%22.6M | 109.80%16.69M | 93.19%10.5M |
| -Interest Income (Financial expense) | 8.13%-19.07M | -5.41%-15.05M | -24.56%-9.25M | 4.86%-26.91M | -0.89%-20.76M | -9.93%-14.27M | -40.73%-7.43M | -156.56%-28.29M | -296.69%-20.58M | -336.80%-12.98M |
| Research and development | -2.85%75.54M | -7.15%48.16M | 22.06%24.69M | 26.37%112.81M | 22.44%77.76M | 38.94%51.87M | 26.71%20.23M | -10.66%89.27M | -10.18%63.5M | -22.98%37.33M |
| Credit Impairment Loss | -76.61%198.51K | -135.68%-110.68K | -108.68%-14.17K | 490.27%2.78M | 14.75%848.74K | 142.46%310.17K | 136.26%163.18K | 48.20%-712.57K | 220.47%739.64K | -27.42%-730.58K |
| Asset Impairment Loss | -217.49%-1.2M | -3.47%-1.12M | -113.74%-318.31K | -84.22%826.15K | -81.71%1.03M | -133.72%-1.08M | -105.22%-148.92K | 137.72%5.23M | 421.57%5.61M | 293.38%3.2M |
| Other net revenue | -49.85%29.85M | -60.49%18.54M | -34.74%19.06M | 27.16%90.31M | 21.38%59.52M | 37.65%46.94M | 682.83%29.21M | -88.22%71.02M | -91.88%49.04M | -94.63%34.1M |
| Fair value change income | -174.21%-7.45M | -156.11%-7.06M | -48.43%3.68M | -3.63%13.37M | 269.83%10.03M | 72.60%12.58M | 175.90%7.15M | 162.90%13.87M | -177.18%-5.91M | -86.15%7.29M |
| Invest income | -25.05%25.49M | -32.84%16.55M | -25.78%8.02M | -5.07%43.62M | -6.04%34M | 23.14%24.64M | 11.82%10.8M | -92.32%45.96M | -93.85%36.19M | -96.54%20.01M |
| -Including: Investment income associates | -12.98%22.82M | -15.02%15.02M | -16.28%6.83M | -15.47%35.81M | -19.67%26.22M | -0.26%17.68M | 5.43%8.15M | 41.26%42.36M | 58.27%32.65M | 52.28%17.72M |
| Asset deal income | 111.93%310.68K | 107.93%204.18K | 237.99%172.32K | 80.42%-2.61M | -352.45%-2.6M | -662.72%-2.57M | 56.26%-124.88K | -592.94%-13.31M | -220.59%-575.62K | 38.49%-337.59K |
| Other revenue | -22.85%12.51M | -22.84%10.08M | -33.86%7.52M | 61.79%32.31M | 24.86%16.21M | 179.43%13.06M | 730.23%11.38M | 23.17%19.97M | 88.77%12.99M | -4.64%4.67M |
| Operating profit | -35.15%40.69M | -59.91%22.64M | -56.32%18.91M | 94.50%79.02M | 143.02%62.74M | 138.58%56.47M | 1,689.38%43.3M | -91.07%40.63M | -95.31%25.82M | -96.05%23.67M |
| Add:Non operating Income | -69.24%427.43K | -80.75%266.09K | 544.71%215.49K | 13.57%2.9M | -43.55%1.39M | 148.42%1.38M | -93.26%33.42K | 230.40%2.55M | 3,323.67%2.46M | 1,009.76%556.39K |
| Less:Non operating expense | 153.04%1.38M | 184.90%1.37M | --74.01 | -82.48%545.16K | -54.47%543.72K | 2,979.20%480.97K | ---- | 14.30%3.11M | 149.08%1.19M | 32.59%15.62K |
| Total profit | -37.50%39.74M | -62.47%21.53M | -55.85%19.13M | 103.08%81.37M | 134.77%63.59M | 136.97%57.37M | 2,041.09%43.33M | -91.15%40.07M | -95.07%27.08M | -95.96%24.21M |
| Less:Income tax cost | -63.40%2.24M | -135.78%-2.48M | -65.95%1.72M | -16.76%11.3M | -27.69%6.13M | 27.20%6.94M | 1,320.41%5.04M | -86.85%13.57M | -21.49%8.47M | -57.96%5.46M |
| Net profit | -34.74%37.5M | -52.37%24.02M | -54.52%17.41M | 164.45%70.08M | 208.73%57.46M | 168.92%50.43M | 2,204.66%38.29M | -92.42%26.5M | -96.55%18.61M | -96.80%18.75M |
| Net profit from continuing operation | -34.74%37.5M | -52.37%24.02M | -54.52%17.41M | 164.45%70.08M | 208.73%57.46M | 168.92%50.43M | 2,204.66%38.29M | -92.42%26.5M | -96.55%18.61M | -96.80%18.75M |
| Less:Minority Profit | -15.75%-3.08M | -28.09%-2.25M | -58.03%-1.38M | 3.33%-3.58M | 2.24%-2.66M | -0.33%-1.76M | -34.12%-870.29K | -191.14%-3.71M | -282.72%-2.73M | -365.73%-1.75M |
| Net profit of parent company owners | -32.50%40.58M | -49.66%26.27M | -52.02%18.79M | 143.86%73.66M | 181.78%60.12M | 154.50%52.19M | 3,445.73%39.16M | -91.39%30.21M | -96.05%21.34M | -96.50%20.51M |
| Earning per share | ||||||||||
| Basic earning per share | -31.58%0.13 | -52.94%0.08 | -53.85%0.06 | 140.00%0.24 | 171.43%0.19 | 142.86%0.17 | --0.13 | -91.15%0.1 | -95.98%0.07 | -96.30%0.07 |
| Diluted earning per share | -31.58%0.13 | -52.94%0.08 | -53.85%0.06 | 140.00%0.24 | 171.43%0.19 | 142.86%0.17 | --0.13 | -91.15%0.1 | -95.98%0.07 | -96.30%0.07 |
| Other composite income | ||||||||||
| Total composite income | -34.74%37.5M | -52.37%24.02M | -54.52%17.41M | 164.45%70.08M | 208.73%57.46M | 168.92%50.43M | 2,204.66%38.29M | -92.42%26.5M | -96.55%18.61M | -96.80%18.75M |
| Total composite income of parent company owners | -32.50%40.58M | -49.66%26.27M | -52.02%18.79M | 143.86%73.66M | 181.78%60.12M | 154.50%52.19M | 3,445.73%39.16M | -91.39%30.21M | -96.05%21.34M | -96.50%20.51M |
| Total composite income of minority owners | -15.75%-3.08M | -28.09%-2.25M | -58.03%-1.38M | 3.33%-3.58M | 2.24%-2.66M | -0.33%-1.76M | -34.12%-870.29K | -191.14%-3.71M | -282.72%-2.73M | -365.73%-1.75M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
